Riversedge Advisors’s Eli Lilly LLY Stock Holding History

Riversedge Advisors’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.39M	Buy	1,159 +336	+41%	+$343K	0.18%	52
2026 Q1	$757K	Buy	823 +75	+10%	+$76K	0.12%	66
2025 Q4	$804K	Buy	748 +276	+58%	+$264K	0.13%	53
2025 Q3	$360K	Buy	472 +179	+61%	+$133K	0.06%	102
2025 Q2	$228K	Sell	293 -82	-22%	-$63.7K	0.04%	111
2025 Q1	$310K	Buy	+375	New	+$312K	0.07%	86
2024 Q4	–	Sell	-235	Closed	-$208K	–	107
2024 Q3	$208K	Sell	235 -13	-5%	-$11.7K	0.05%	87
2024 Q2	$225K	Buy	+248	New	+$198K	0.05%	82

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

ONB

Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

GIM

Goelzer Investment Management Carmel, Indiana $2.29B AUM 39.12% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Riversedge Advisors's LLY Position: Q2 2026 in Review

Riversedge Advisors increased its Eli Lilly (LLY) stake by 41% in Q2 2026, buying an estimated $343K and bringing the position to 1,159 shares worth $1.39M. The position accounts for 0.18% of the portfolio, ranked #52.

Riversedge Advisors first reported a position in LLY in Q2 2024 and has held it in 8 quarters since. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Riversedge Advisors held 1,159 shares of Eli Lilly worth $1.39M as of Q2 2026.
Riversedge Advisors bought 336 Eli Lilly shares in Q2 2026, an estimated $343K.
Eli Lilly made up 0.18% of Riversedge Advisors's portfolio in Q2 2026, its #52 holding.
Riversedge Advisors first reported a position in Eli Lilly in Q2 2024 and has held it in 8 quarters since.
1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Riversedge Advisors's 13F filing for Q2 2026, filed 16 Jul 2026.